Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin eye drops for dry eye in glaucoma patients
NCT06017362Phase 4Recruiting
- Start
- Feb 2023
- Primary completion
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Generex Oral-lyn in dry eye disease (DED). Started Feb 2023; status: recruiting.
02
Drugs
Generex Oral-lyn
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06017362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06017362.